Cargando…
Oral application of magnesium‐L‐threonate enhances analgesia and reduces the dosage of opioids needed in advanced cancer patients—A randomized, double‐blind, placebo‐controlled trial
PURPOSE: To investigate the effects of oral administration of magnesium‐L‐threonate, a novel magnesium compound, on the analgesic effect of opioids in patients with advanced cancer. METHODS: We performed a prospective, randomized, double‐blind trial at a tertiary hospital in Shanghai, China. Eligibl...
Autores principales: | Wu, Siyin, Jin, Tian, Ma, Bingjie, Ji, Yun, Huang, Xuehua, Wang, Peiliang, Liu, Xiaoming, Krylov, Boris V., Liu, Xianguo, Ma, Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972038/ https://www.ncbi.nlm.nih.gov/pubmed/36703238 http://dx.doi.org/10.1002/cam4.4922 |
Ejemplares similares
-
Neuroprotective effects of magnesium l-threonate in a hypoxic zebrafish model
por: Kim, Young-Sung, et al.
Publicado: (2020) -
A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Therapeutic Effect of Magnesium-L-Threonate Supplementation for Persistent Pain After Breast Cancer Surgery
por: Ni, Yuncheng, et al.
Publicado: (2023) -
Effects of Vitamin C and Magnesium L-threonate Treatment on Learning and Memory in Lead-poisoned Mice
por: Bislimi, Kemajl, et al.
Publicado: (2021) -
A Magtein(®), Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults
por: Zhang, Chengxiang, et al.
Publicado: (2022) -
Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
por: Shen, Yanling, et al.
Publicado: (2019)